MeSH tree: C23.888.144
People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU ...
18 hours ago
0
18
Researchers at Pennington Biomedical Research Center have identified a key brain mechanism that connects environmental temperature with appetite and energy balance, offering new insight into how external conditions can shape ...
Oct 5, 2026
0
12
Around half of people who are severely overweight have mild inflammation in their bodies. Research by neuroscientist Judith Scholing of the Donders Institute at Radboud University shows that this inflammation can cause people ...
Oct 5, 2026
0
38
Providing people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension. However, most studies of "Food Is Medicine" programs have only looked at their short-term ...
Oct 4, 2026
0
137
Researchers believe broader societal changes beginning around 2009 to 2010 severely affected the mental health of an entire generation of young people, according to research presented during the American Academy of Pediatrics ...
Oct 2, 2026
0
10
New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and appearing in The Lancet Regional Health Americas journal shows that in people ...
Oct 2, 2026
0
381
More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
Oct 1, 2026
0
18
The world's first clinical trial of feijoa has provided preliminary evidence that the fruit reduces blood pressure during weight loss. The unexpected finding was incidental to studying feijoa's potential for preventing type ...
Oct 1, 2026
0
73
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and appearing in The Lancet shows that treatment with the new triple agonist ...
Oct 1, 2026
0
100
New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), show that, for people living with obesity and type ...
Sep 30, 2026
0
119
